Determination of the Aneurysm Vulnerability Index by Stimulation and Medical Imaging
NCT ID: NCT05189041
Last Updated: 2022-01-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
45 participants
INTERVENTIONAL
2014-06-30
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Nevertheless, access to brain imaging allows the detection of an increasing number of intracranial aneurysms. The question of preventive treatment then arises and is still a difficult point discussed by neurosurgeons / neurointerventionists based on general epidemiological data difficult to apply to an individual.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Functional Neuroimaging and Genetic Vulnerability to Suicidal Behavior
NCT02960191
Prediction of Delayed Cerebral Ischemia After Subarachnoid Hemorrhage Using Dynamic 18F-FDG PET/CT
NCT04356599
VIsual Cerebral ConnecTivity On Functional Magnetic Resonance Imaging in Patients With Hereditary REtinal Dystrophies
NCT04648124
Super-resolution Clinical Brain Ultrasound
NCT05785598
Cortical Superficial Siderosis and Risk of Recurrent Intracerebral Hemorrhage in Cerebral Amyloid Angiopathy.
NCT03464344
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ruptured Cerebral Aneurysm
Quantify the aneurysmal pulsation in functional MRI on the patient with Ruptured Cerebral Aneurysm
Aneurysmal pulsation in functional MRI
Quantify the aneurysmal pulsation in functional MRI on the patient with Ruptured Cerebral Aneurysm
Non Ruptured Cerebral Aneurysm
Quantify the aneurysmal pulsation in functional MRI on the patient with Non Ruptured Cerebral Aneurysm
Aneurysmal pulsation in functional MRI
Quantify the aneurysmal pulsation in functional MRI on the patient with Ruptured Cerebral Aneurysm
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Aneurysmal pulsation in functional MRI
Quantify the aneurysmal pulsation in functional MRI on the patient with Ruptured Cerebral Aneurysm
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Collection of the informed consent (patient or legal representant)
* Affiliation or recipient with the mode of social security
\- Groupe anévrysme rompu
* Patient porteur d'un anévrysme rompu
\- Groupe anévrysme non rompu
* Patient porteur d'un anévrysme non rompu
Exclusion Criteria
* Claustrophobia
* Women pregnant or Breast-feeding
* Patient participating in an other study
* Patient have participated in a study in the 3 months before the inclusion
* In period of exclusion relative to another protocol
* Person with majority age protected by the law (supervision or trusteeship).
* Patient not reading the french language
* Patient or representant for whom it impossible to give accurate informations
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Montpellier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
VINCENT COSTALAT
Role: STUDY_DIRECTOR
University Hospital, Montpellier
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
COSTALAT
Montpellier, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
9364
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.